跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ALENDRONATE/VITAMIN D3 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
APO-ALENDRONATE/VITAMIN D3
Authorized
STANDARD
APO-ALENDRONATE/VITAMIN D3
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
eb0613401970186b
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
eb0613401970186b
Drug Approval Canada Name
APO-ALENDRONATE/VITAMIN D3
Product Name
APO-ALENDRONATE/VITAMIN D3
Status
Marketed
Status Date
2016-07-21
Original Market Date
2016-07-21
Din
02454475
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:24.00
Atc Original
M05BB03 ALENDRONIC ACID AND CHOLECALCIFEROL
Atc Name
m 05 bb 03
Aig Number
0251575002
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
VITAMIN D3 (VITAMIN D3)
5600 UNIT
ALENDRONIC ACID (ALENDRONATE SODIUM)
70 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
eb0613401970186b
Type
Standard
Back to Health Canada Approvals